Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Ordinary Shares
-
Shares outstanding
-
2.18B
-
Number of holders
-
1176
-
Total 13F shares, excl. options
-
148M
-
Shares change
-
-23.3M
-
Total reported value, excl. options
-
$14.9B
-
Value change
-
-$2.34B
-
Put/Call ratio
-
0.34
-
Number of buys
-
412
-
Number of sells
-
-533
-
Price
-
$100.91
Significant Holders of NOVARTIS AG - Ordinary Shares (NVS) as of Q2 2023
1,294 filings reported holding NVS - NOVARTIS AG - Ordinary Shares as of Q2 2023.
NOVARTIS AG - Ordinary Shares (NVS) has 1,176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 148M shares
of 2.18B outstanding shares and own 6.77% of the company stock.
Largest 10 shareholders include Dodge & Cox (16.4M shares), PRIMECAP MANAGEMENT CO/CA/ (15M shares), MORGAN STANLEY (7.27M shares), LOOMIS SAYLES & CO L P (6.32M shares), DIMENSIONAL FUND ADVISORS LP (6.26M shares), FRANKLIN RESOURCES INC (6.18M shares), BANK OF AMERICA CORP /DE/ (4.99M shares), WELLINGTON MANAGEMENT GROUP LLP (4.75M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (4.41M shares), and GOLDMAN SACHS GROUP INC (2.9M shares).
This table shows the top 1176 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.